Cardioprotective Peptides from Milk Processing and Dairy Products: From Bioactivity to Final Products including Commercialization and Legislation

Recent research has revealed the potential of peptides derived from dairy products preventing cardiovascular disorders, one of the main causes of death worldwide. This review provides an overview of the main cardioprotective effects (assayed in vitro, in vivo, and ex vivo) of bioactive peptides deri...

Full description

Bibliographic Details
Main Authors: Armin Mirzapour-Kouhdasht, Marco Garcia-Vaquero
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Foods
Subjects:
Online Access:https://www.mdpi.com/2304-8158/11/9/1270
_version_ 1797504832593985536
author Armin Mirzapour-Kouhdasht
Marco Garcia-Vaquero
author_facet Armin Mirzapour-Kouhdasht
Marco Garcia-Vaquero
author_sort Armin Mirzapour-Kouhdasht
collection DOAJ
description Recent research has revealed the potential of peptides derived from dairy products preventing cardiovascular disorders, one of the main causes of death worldwide. This review provides an overview of the main cardioprotective effects (assayed in vitro, in vivo, and ex vivo) of bioactive peptides derived from different dairy processing methods (fermentation and enzymatic hydrolysis) and dairy products (yogurt, cheese, and kefir), as well as the beneficial or detrimental effects of the process of gastrointestinal digestion following oral consumption on the biological activities of dairy-derived peptides. The main literature available on the structure–function relationship of dairy bioactive peptides, such as molecular docking and quantitative structure–activity relationships, and their allergenicity and toxicity will also be covered together with the main legislative frameworks governing the commercialization of these compounds. The current products and companies currently commercializing their products as a source of bioactive peptides will also be summarized, emphasizing the main challenges and opportunities for the industrial exploitation of dairy bioactive peptides in the market of functional food and nutraceuticals.
first_indexed 2024-03-10T04:09:59Z
format Article
id doaj.art-3478b1e7a2084c389a831a53cea7c920
institution Directory Open Access Journal
issn 2304-8158
language English
last_indexed 2024-03-10T04:09:59Z
publishDate 2022-04-01
publisher MDPI AG
record_format Article
series Foods
spelling doaj.art-3478b1e7a2084c389a831a53cea7c9202023-11-23T08:13:07ZengMDPI AGFoods2304-81582022-04-01119127010.3390/foods11091270Cardioprotective Peptides from Milk Processing and Dairy Products: From Bioactivity to Final Products including Commercialization and LegislationArmin Mirzapour-Kouhdasht0Marco Garcia-Vaquero1School of Agriculture and Food Science, University College Dublin, Belfield, Dublin 4, D04 V1W8 Dublin, IrelandSchool of Agriculture and Food Science, University College Dublin, Belfield, Dublin 4, D04 V1W8 Dublin, IrelandRecent research has revealed the potential of peptides derived from dairy products preventing cardiovascular disorders, one of the main causes of death worldwide. This review provides an overview of the main cardioprotective effects (assayed in vitro, in vivo, and ex vivo) of bioactive peptides derived from different dairy processing methods (fermentation and enzymatic hydrolysis) and dairy products (yogurt, cheese, and kefir), as well as the beneficial or detrimental effects of the process of gastrointestinal digestion following oral consumption on the biological activities of dairy-derived peptides. The main literature available on the structure–function relationship of dairy bioactive peptides, such as molecular docking and quantitative structure–activity relationships, and their allergenicity and toxicity will also be covered together with the main legislative frameworks governing the commercialization of these compounds. The current products and companies currently commercializing their products as a source of bioactive peptides will also be summarized, emphasizing the main challenges and opportunities for the industrial exploitation of dairy bioactive peptides in the market of functional food and nutraceuticals.https://www.mdpi.com/2304-8158/11/9/1270bioactive peptidescardioprotective peptidesdairy processingdairy products
spellingShingle Armin Mirzapour-Kouhdasht
Marco Garcia-Vaquero
Cardioprotective Peptides from Milk Processing and Dairy Products: From Bioactivity to Final Products including Commercialization and Legislation
Foods
bioactive peptides
cardioprotective peptides
dairy processing
dairy products
title Cardioprotective Peptides from Milk Processing and Dairy Products: From Bioactivity to Final Products including Commercialization and Legislation
title_full Cardioprotective Peptides from Milk Processing and Dairy Products: From Bioactivity to Final Products including Commercialization and Legislation
title_fullStr Cardioprotective Peptides from Milk Processing and Dairy Products: From Bioactivity to Final Products including Commercialization and Legislation
title_full_unstemmed Cardioprotective Peptides from Milk Processing and Dairy Products: From Bioactivity to Final Products including Commercialization and Legislation
title_short Cardioprotective Peptides from Milk Processing and Dairy Products: From Bioactivity to Final Products including Commercialization and Legislation
title_sort cardioprotective peptides from milk processing and dairy products from bioactivity to final products including commercialization and legislation
topic bioactive peptides
cardioprotective peptides
dairy processing
dairy products
url https://www.mdpi.com/2304-8158/11/9/1270
work_keys_str_mv AT arminmirzapourkouhdasht cardioprotectivepeptidesfrommilkprocessinganddairyproductsfrombioactivitytofinalproductsincludingcommercializationandlegislation
AT marcogarciavaquero cardioprotectivepeptidesfrommilkprocessinganddairyproductsfrombioactivitytofinalproductsincludingcommercializationandlegislation